Company intelligence / Profile preview

Hona

Ownership: Private
Development stage: Other

Overview

Hona has developed an AI-powered tool that integrates into multiple electronic health record systems. It summarizes patient records tailored to specific clinician needs—e.g., providing different summaries for cardiologists versus nephrologists. The product has been tested at major academic centers like Duke and Harvard, with positive feedback from doctors. A white paper on its use in kidney stone referrals was due mid-2024. The company raised $3 million from notable investors after graduating from Y Combinator's Winter 2024 batch

Industry: Digital Health Medical Devices

Partnerships

Academic pilots at Duke University and Harvard University hospitals/clinics [pending publication]

Beyond the preview

Go deeper on Hona.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hona.

Explore the full profile